Buy Cardarine (GW501516) 10mg x30 Capsules

Cardarine (GW501516) is a PPARδ (Peroxisome Proliferator-Activated Receptor delta) agonist that fundamentally changes how cells generate energy — favoring fat oxidation over glucose utilization and dramatically increasing mitochondrial density in skeletal muscle. In animal studies, Cardarine increased running endurance by 68% and produced a lean body composition phenotype without caloric restriction.

▸The PPARδ Mechanism

PPARδ activation triggers a metabolic reprogramming that shifts the primary fuel source in muscle from glucose to fatty acids. This produces two major benefits: (1) virtually unlimited endurance limited only by fat stores rather than glycogen, and (2) enhanced fat mobilization that produces body composition changes independent of caloric restriction. The effect is sometimes described as "exercise gene" activation.

▸AMPK Synergy

Cardarine synergizes powerfully with AICAR (AMPK activator) — the two compounds act on different upstream regulators that converge on the same fat-burning and mitochondrial biogenesis pathways. Together they produce greater endurance and metabolic improvements than either alone, which is why the Cardarine + AICAR stack was informally known as the "drug that passed all the doping tests" in endurance sports research.

▸Safety Context

GW501516 was discontinued from pharmaceutical development after showing dose-dependent carcinogenicity in animal studies at doses far exceeding typical research applications. This context is important for informed use — the doses used in the animal studies (3-10mg/kg, far exceeding human research doses) showed these effects; the clinical relevance at low human doses remains debated in the research community.